
Keri Lunsford
Director of Translational Research · Rutgers Health
Credentials: · · · · · · · ·
History
- Present
- Present
2013–2014
2007–2013
Research
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Hepatology · 2023 · 350 citations
The Lancet. Gastroenterology & hepatology · 2018 · First of 21 authors · 225 citations
Annals of Surgery · 2017 · 161 citations

21 papers
- GP
14 papers · 9 as a resident
- FP
11 papers

11 papers
- AA
10 papers · 3 as a fellow

8 papers
- PH
8 papers · 1 as a fellow

7 papers
Grants
- 2024–2029
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $2.1M · Rutgers Biomedical and Health Sciences
- 2024–2027
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $425.8K · Rutgers Biomedical and Health Sciences
- 2019–2024
Defining Immunology Frailty as a Predictor of Human Liver Allograft Recipient Futility
National Institute of Diabetes and Digestive and Kidney Diseases · K08
Contact PI · $1.1M · Rutgers Biomedical and Health Sciences
Clinical trials
- 2023–2029
Liver Transplantation in Intrahepatic Cholangiocarcinoma
Principal investigator · Recruiting
Rutgers, The State University of New Jersey



